Sullivan Lucy C, Orgeig Sandra, Daniels Christopher B
Department of Environmental Biology, University of Adelaide, Adelaide, South Australia 5005, Australia.
Physiol Biochem Zool. 2003 May-Jun;76(3):281-95. doi: 10.1086/375434.
Pulmonary surfactant is a mixture of lipids and proteins that is secreted by alveolar Type II cells. It reduces alveolar surface tension and hence the work of breathing. Despite the tremendous diversity of lung structures amongst the vertebrates, the composition of surfactant is highly conserved. Conserved elements of the surfactant system amongst distantly related species are likely to be crucial factors for successful lung development. Understanding the mechanisms by which the surfactant system becomes operational in animals with dramatically different birthing strategies and in distantly related species will provide important information about the role of the surfactant system in the commencement of air breathing and the processes regulating surfactant maturation and secretion. In mammals, the embryonic maturation of the surfactant system is controlled by a host of factors, including glucocorticoids, thyroid hormones, and autonomic neurotransmitters. Here we review the mechanisms controlling the maturation of surfactant production, including birthing strategy, phylogeny, lung structure, and posthatching environment. Using four species of egg-laying amniote (chicken, dragon lizard, sea turtle, and crocodile) previously described in detail and the large amount of information available for mammals, we examine the hypothesis that the control of surfactant production is dependent on glucocorticoids (dexamethasone [Dex]), thyroid hormones (T3), and autonomic neurotransmitters (epinephrine and carbachol). We also examine whether the overall intrinsic pattern of the control of surfactant maturation is conserved throughout the vertebrate radiation and then how the environment (extrinsic factors) may account for the observed differences in the patterns of development. We also discuss the utility of a coculture system of embryonic Type II cells and fibroblasts to determine the evolutionary pattern behind the control of surfactant and to demonstrate that the surfactant system matures under multihormonal control. We demonstrate that Dex and T3 are stimulators of surfactant production during embryonic development, but they lose their efficacy closer to hatching or birth. Epinephrine stimulates surfactant secretion beyond 75% of development and also after hatching or birth. Carbachol stimulates surfactant secretion in the bearded dragon and saltwater crocodile but not in the sea turtle, chicken, or mammals. It is likely that the differences in control of surfactant development are likely to be primarily related to metabolic activity and the duration of incubation (i.e., the "speed" of development). Moreover, the hormones examined appear important in promoting development and therefore appear conserved within the amniotes. However, the autonomic neurotransmitters induced different responses in different species. Hence, some factors are crucial for the proper maturation of the surfactant system, whereas others vary throughout evolution without being detrimental to the overall function of the system.
肺表面活性物质是一种由肺泡II型细胞分泌的脂质和蛋白质混合物。它可降低肺泡表面张力,从而减轻呼吸做功。尽管脊椎动物的肺结构千差万别,但表面活性物质的组成却高度保守。远缘物种间表面活性物质系统的保守成分可能是肺成功发育的关键因素。了解表面活性物质系统在具有截然不同分娩策略的动物以及远缘物种中发挥作用的机制,将为表面活性物质系统在开始呼吸以及调节表面活性物质成熟和分泌过程中的作用提供重要信息。在哺乳动物中,表面活性物质系统的胚胎成熟受多种因素控制,包括糖皮质激素、甲状腺激素和自主神经递质。在此,我们综述控制表面活性物质产生成熟的机制,包括分娩策略、系统发育、肺结构和孵化后环境。利用先前详细描述的四种产卵羊膜动物(鸡、鬃狮蜥、海龟和鳄鱼)以及可获取的大量哺乳动物信息,我们检验了表面活性物质产生的控制依赖于糖皮质激素(地塞米松[Dex])、甲状腺激素(T3)和自主神经递质(肾上腺素和卡巴胆碱)这一假说。我们还研究了表面活性物质成熟控制的整体内在模式在整个脊椎动物辐射过程中是否保守,以及环境(外在因素)如何解释观察到的发育模式差异。我们还讨论了胚胎II型细胞与成纤维细胞共培养系统在确定表面活性物质控制背后的进化模式以及证明表面活性物质系统在多种激素控制下成熟方面的效用。我们证明,Dex和T3在胚胎发育过程中是表面活性物质产生的刺激物,但在接近孵化或出生时它们会失去效力。肾上腺素在发育超过75%时以及孵化或出生后刺激表面活性物质分泌。卡巴胆碱刺激鬃狮蜥和咸水鳄中的表面活性物质分泌,但不刺激海龟、鸡或哺乳动物中的表面活性物质分泌。表面活性物质发育控制的差异可能主要与代谢活性和孵化持续时间(即发育“速度”)有关。此外,所研究的激素在促进发育方面似乎很重要,因此在羊膜动物中似乎是保守的。然而,自主神经递质在不同物种中引发了不同反应。因此,一些因素对表面活性物质系统的正常成熟至关重要,而其他因素在整个进化过程中有所不同,但对系统整体功能并无损害。